Lincoln Hirayama

A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation

A. Spivak, B. Worthen, M. Astill, 2021, Scientific Reports.

A rapid and affordable point-of-care test for detection of SARS-CoV-2-specific antibodies based on hemagglutination and Artificial Intelligence-based image interpretation

A. Spivak, B. Worthen, H. Haecker, 2021, Research square.